Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP14 | P50281 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55940 | 1.00 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL2965177 | 0.91 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL3457667 | 0.87 | — | — | |
| SCHEMBL16115561 | 0.84 | — | — | |
| SCHEMBL178113 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL3900949 | 0.81 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL6009237 | 0.80 | TDP1 (0.35) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL4279142 | 0.80 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL594300 | 0.79 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1CYP3A4CA2 | |
| SCHEMBL27639365 | 0.77 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1CYP3A4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9293720-B2 | Carbon nanotubes as charge carriers in organic and hybrid solar cells | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2016-03-22 | — | — | US | disclosed |
| US-8501981-B2 | CXCR2 inhibitors | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-20090227625-A1 | CXCR2 INHIBITORS | SANOFI-AVENTIS (FR) | 2009-09-10 | — | — | US | disclosed |
| US-20090205713-A1 | Carbon Nanotubes As Charge Carriers In Organic and Hybrid Solar Cells | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227625-A1 | CXCR2 INHIBITORS | CXCR2, CXCR1, CXCR4 | ALDH1A1 2011/4885TSHR 1459/4885MAPK1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.